XML 15 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2017
Dec. 31, 2016
Current Assets:    
Cash and cash equivalents $ 26,562,000 $ 27,715,000
Short-term investments 4,993,000 0
Accounts receivable 11,878,000 9,073,000
Inventories 9,275,000 5,327,000
Deferred costs 505,000 1,773,000
Prepaid expenses and other current assets 2,323,000 1,376,000
Total current assets 55,536,000 45,264,000
Equipment, molds, furniture and fixtures, net 16,158,000 17,867,000
Patent rights, net 1,401,000 2,045,000
Goodwill 1,095,000 1,095,000
Other assets 148,000 54,000
Total Assets 74,338,000 66,325,000
Current Liabilities:    
Accounts payable 5,957,000 7,885,000
Accrued expenses and other liabilities 6,982,000 5,873,000
Deferred revenue 2,794,000 6,149,000
Total current liabilities 15,733,000 19,907,000
Long-term debt 24,858,000  
Deferred revenue – long term 200,000 1,200,000
Total liabilities 40,791,000 21,107,000
Stockholders’ Equity:    
Preferred Stock: $0.01 par, authorized 3,000,000 shares, none outstanding
Common Stock: $0.01 par; authorized 300,000,000 shares; 156,674,504 and 155,167,677 issued and outstanding at December 31, 2017 and 2016, respectively 1,567,000 1,552,000
Additional paid-in capital 302,965,000 297,826,000
Accumulated deficit (270,285,000) (253,445,000)
Accumulated other comprehensive loss (700,000) (715,000)
Total Stockholders' Equity 33,547,000 45,218,000
Total Liabilities and Stockholders’ Equity $ 74,338,000 $ 66,325,000